JP2005500812A5 - - Google Patents

Download PDF

Info

Publication number
JP2005500812A5
JP2005500812A5 JP2002556623A JP2002556623A JP2005500812A5 JP 2005500812 A5 JP2005500812 A5 JP 2005500812A5 JP 2002556623 A JP2002556623 A JP 2002556623A JP 2002556623 A JP2002556623 A JP 2002556623A JP 2005500812 A5 JP2005500812 A5 JP 2005500812A5
Authority
JP
Japan
Prior art keywords
seq
compound
peptide
subject
following structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002556623A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005500812A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/049964 external-priority patent/WO2002055555A2/en
Publication of JP2005500812A publication Critical patent/JP2005500812A/ja
Publication of JP2005500812A5 publication Critical patent/JP2005500812A5/ja
Withdrawn legal-status Critical Current

Links

JP2002556623A 2000-12-21 2001-12-21 治療および診断のための抗原性ｃｋ−１８化合物ならびにその使用方法 Withdrawn JP2005500812A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25782000P 2000-12-21 2000-12-21
PCT/US2001/049964 WO2002055555A2 (en) 2000-12-21 2001-12-21 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same

Publications (2)

Publication Number Publication Date
JP2005500812A JP2005500812A (ja) 2005-01-13
JP2005500812A5 true JP2005500812A5 (enExample) 2005-12-22

Family

ID=22977885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002556623A Withdrawn JP2005500812A (ja) 2000-12-21 2001-12-21 治療および診断のための抗原性ｃｋ−１８化合物ならびにその使用方法

Country Status (5)

Country Link
US (1) US20020122791A1 (enExample)
EP (1) EP1345961A2 (enExample)
JP (1) JP2005500812A (enExample)
CA (1) CA2432883A1 (enExample)
WO (1) WO2002055555A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980568B2 (en) 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
US8986944B2 (en) 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
WO2005074968A2 (en) * 2004-02-10 2005-08-18 Universiteit Maastricht Medical use of basic peptides
KR100756972B1 (ko) * 2005-02-05 2007-09-07 전숙영 만성폐쇄성폐질환의 예방, 치료 및 진단용 조성물 및 방법
CA2657621A1 (en) 2006-07-14 2008-01-17 Aviva Biosciences Corporation Methods and compositions for detecting rare cells from a biological sample

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4754065A (en) * 1984-12-18 1988-06-28 Cetus Corporation Precursor to nucleic acid probe
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5837249A (en) * 1985-04-19 1998-11-17 The Wistar Institute Method for generating an immunogenic T cell response protective against a virus
US4800159A (en) * 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
SE470273B (sv) * 1990-09-24 1993-12-20 Idl Immunodeveloplab Ab Cytokeratinfragment, deras framställning och användning, framställning av monoklonala antikroppar och testkit för epitelialcancer
EP0573608A1 (en) * 1991-02-07 1993-12-15 Molecumetics, Ltd. Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
SE9500023L (sv) * 1994-05-17 1995-11-18 Beki Ab Sätt att detektera cancer
DE19716346C1 (de) * 1997-04-18 1998-11-19 Christoph Prof Dr Wagener Verfahren zum Nachweis von Cytokeratinen

Similar Documents

Publication Publication Date Title
JP2002509854A5 (enExample)
TR199701071T2 (xx) Aktif madde ula�t�rmaya mahsus bile�ikler ve terkipler.
JP2012501959A5 (enExample)
EP1944371A3 (en) Neisseria meningitidis antigens and compositions
NZ512056A (en) HBV core antigen particles with multiple immunogenic components attached via peptide ligands
EP2258384A3 (en) Neisseria vaccine composition
EP2360259A3 (en) Promyostatin peptides and methods of using same
JP2008530245A5 (enExample)
NZ504894A (en) Crystalline vaccine and adjuvant compositions jointly and separately administered to animals using a transdermal or transmucosally delivery technique
EP2145897A3 (en) Therapeutic methods and compositions based on serrate proteins and nucleic acids
JP2013502918A5 (enExample)
EP2258725A3 (en) Cytokine receptor zcytor17
IL142905A0 (en) Functional antagonists of hedgehog activity
ES8606494A1 (es) Un metodo de producir un peptido o polipeptido sintetico.
JP2002528123A5 (enExample)
EP1455821A4 (en) PARATHYROID HORMONE ANTIBODIES AND RELATED METHODS
EP1932915A3 (en) Materials and methods relating to improved vaccination strategies
JP2006515744A5 (enExample)
WO2000012535A3 (en) Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
JP2004504260A5 (enExample)
DE69229269D1 (de) Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik
EP0161007A3 (en) Retro - inverso c-terminal hexapeptide analogues of substance p
JP2010535504A5 (enExample)
BR0309491A (pt) Composição de vacina, composição imunogênica, utilização de uma proteìna e7 e anticorpos neutralizantes
EP0348725A3 (en) Species-specific epitode of chlamydia trachomatis and antibodies that recognize the same